Opposition · USPTO

Opposition 91245213

OtherUSPTO

Opposition 91245213 at USPTO between Societe des Produits Nestle S.A. and Chris J. Jacobsen, over the mark VITALITY ELIXRX, filed Dec 10, 2018. Status in the office record: other.

View VITALITY ELIXRXGet this data via the API
Status
Other
Result
Other
Filed
Dec 10, 2018
Marks involved
7
Parties

Who is involved

The parties as named in the office record.

Opponent

Societe des Produits Nestle S.A.

Company trademarks
Respondent

Chris J. Jacobsen

Timeline

How the case has moved

Dates from the USPTO record and the VITALITY ELIXRX filing.

  1. VITALITY ELIXRX filed

    Application 87606278 filed at the USPTO.

  2. Opposition filed

    Societe des Produits Nestle S.A. started opposition 91245213 at USPTO against VITALITY ELIXRX.
Marks

Marks involved

1 contested mark, 6 marks the challenger relies on.

MarkRoleApplicationOffice
VITALITY ELIXRXContested87606278USPTO
VITALITYRelied on72325533USPTO
VITALITYRelied on72438282USPTO
VITALITY EXPRESSRelied on74253662USPTO
VITALITYRelied on75385646USPTO
NESTLE VITALITYRelied on85967711USPTO
NESTLE VITALITYRelied on85967717USPTO
API

Get this data via the API

Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.

  • GET/v1/proceedings/{id}

    Parties, dates, outcome and every mark in the case

  • GET/v1/proceedings?trademark_id={trademark_id}

    Every proceeding on a mark

Get API keyView docs
GET /v1/proceedings/{id}
ID=prc_faa7d17b-9fc8-4730-b478-52b638fd704b
curl https://api.signa.so/v1/proceedings/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "prc_faa7d17b-9fc8-4730-b478-52b638fd704b",
  "object": "proceeding",
  "proceeding_type": "opposition",
  "proceeding_number": "91245213",
  "status": "other",
  "office_code": "US",
  "filed_date": "2018-12-10",
  "parties": [
    {
      "name": "Societe des Produits Nestle S.A.",
      "role": "opponent"
    },
    {
      "name": "Chris J. Jacobsen",
      "role": "respondent"
    }
  ]
}